201 related articles for article (PubMed ID: 22860174)
21. 2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Novellino E; Cosimelli B; Ehlardo M; Greco G; Iadanza M; Lavecchia A; Rimoli MG; Sala A; Da Settimo A; Primofiore G; Da Settimo F; Taliani S; La Motta C; Klotz KN; Tuscano D; Trincavelli ML; Martini C
J Med Chem; 2005 Dec; 48(26):8253-60. PubMed ID: 16366607
[TBL] [Abstract][Full Text] [Related]
22. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
[TBL] [Abstract][Full Text] [Related]
23. 2-Aminopyrimidines as dual adenosine A1/A2A antagonists.
Robinson SJ; Petzer JP; Terre'Blanche G; Petzer A; van der Walt MM; Bergh JJ; Lourens AC
Eur J Med Chem; 2015 Nov; 104():177-88. PubMed ID: 26462195
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
[TBL] [Abstract][Full Text] [Related]
26. 5-Substituted 2-benzylidene-1-tetralone analogues as A
Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ
Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease.
Ikeda K; Kurokawa M; Aoyama S; Kuwana Y
J Neurochem; 2002 Jan; 80(2):262-70. PubMed ID: 11902116
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.
Federico S; Paoletta S; Cheong SL; Pastorin G; Cacciari B; Stragliotto S; Klotz KN; Siegel J; Gao ZG; Jacobson KA; Moro S; Spalluto G
J Med Chem; 2011 Feb; 54(3):877-89. PubMed ID: 21214204
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.
Sullivan GW; Rieger JM; Scheld WM; Macdonald TL; Linden J
Br J Pharmacol; 2001 Mar; 132(5):1017-26. PubMed ID: 11226132
[TBL] [Abstract][Full Text] [Related]
30. Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).
Stasi MA; Minetti P; Lombardo K; Riccioni T; Caprioli A; Vertechy M; Di Serio S; Pace S; Borsini F
Eur J Pharmacol; 2015 Aug; 761():353-61. PubMed ID: 25936513
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin-releasing factor (CRF) in glutamate injured cortical neurons.
Valadas JS; Batalha VL; Ferreira DG; Gomes R; Coelho JE; Sebastião AM; Diógenes MJ; Lopes LV
J Neurochem; 2012 Dec; 123(6):1030-40. PubMed ID: 23057965
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N
J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118
[TBL] [Abstract][Full Text] [Related]
34. Geometrically constrained analogues of N-benzylindolylglyoxylylamides: [1, 2, 4]triazino[4, 3-a]benzimidazol-4(10H)-one derivatives as potential new ligands at the benzodiazepine receptor.
Primofiore G; Da Settimo F; Taliani S; Marini AM; Simorini F; Novellino E; Greco G; Trincavelli L; Martini C
Arch Pharm (Weinheim); 2003 Sep; 336(9):413-21. PubMed ID: 14528489
[TBL] [Abstract][Full Text] [Related]
35. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
36. The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A
Squarcialupi L; Betti M; Catarzi D; Varano F; Falsini M; Ravani A; Pasquini S; Vincenzi F; Salmaso V; Sturlese M; Varani K; Moro S; Colotta V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):248-263. PubMed ID: 28114825
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.
Petzer JP; Steyn S; Castagnoli KP; Chen JF; Schwarzschild MA; Van der Schyf CJ; Castagnoli N
Bioorg Med Chem; 2003 Apr; 11(7):1299-310. PubMed ID: 12628657
[TBL] [Abstract][Full Text] [Related]
39. Involvement of K(ATP)/PI (3)K/AKT/Bcl-2 pathway in hydrogen sulfide-induced neuroprotection against the toxicity of 1-methy-4-phenylpyridinium ion.
Tang XQ; Zhuang YY; Fan LL; Fang HR; Zhou CF; Zhang P; Hu B
J Mol Neurosci; 2012 Feb; 46(2):442-9. PubMed ID: 21800153
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.
Congreve M; Andrews SP; Doré AS; Hollenstein K; Hurrell E; Langmead CJ; Mason JS; Ng IW; Tehan B; Zhukov A; Weir M; Marshall FH
J Med Chem; 2012 Mar; 55(5):1898-903. PubMed ID: 22220592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
